![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | |
C07K 14/47 | |||
A61K 48/00 | |||
C07K 16/40 | |||
C12N 15/00 | |||
A61P 25/28 | |||
A61P 3/10 | |||
A61P 41/00 | |||
A61P 13/12 | |||
A61K 38/55 | |||
A61P 1/00 | |||
A61P 1/02 | |||
A61P 1/04 | |||
A61P 1/16 | |||
A61P 1/18 | |||
A61P 3/00 | |||
A61P 3/08 | |||
A61P 5/00 |
(11) | Number of the document | 3013353 |
(13) | Kind of document | T |
(96) | European patent application number | 14734003.8 |
Date of filing the European patent application | 2014-06-26 | |
(97) | Date of publication of the European application | 2016-05-04 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/001736 |
Date | 2014-06-26 |
(87) | Number | WO 2014/206563 |
Date | 2014-12-31 |
(30) | Number | Date | Country code |
PCT/EP2013/0018 | 2013-06-26 | WO | |
PCT/EP2013/0018 | 2013-06-27 | WO |
(72) |
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
|
(73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
(54) | CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |